Last updated on November 2019

An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide Each Given With Radiation Therapy for Newly-diagnosed Patients With Glioblastoma (GBM a Malignant Brain Cancer)


Find a site near you

Start Over

Local Institution

Hiroshima-Shi, Japan
0.61miles
  Connect »